What is Driving the Adeno-Associated Virus Vector-Based Gene Therapy Market? The adeno-associated virus (AAV) vector-based gene therapy market has emerged as a revolutionary segment in biotechnology, offering targeted treatment for rare genetic disorders, cancers, and inherited conditions. AAV vectors are non-pathogenic viral vectors widely used in gene therapy due to their high safety profile,...